CapyFin

Calendar Reports Pricing

Search for a symbol...

Loading...

CapyFin Real-time Earnings Reports.

Products

Earnings
API

Get in Touch

Contact Us
X (Twitter)
LinkedIn

Resources

Privacy Policy
Terms of Service
Sign Up
Sign In

© 2026 CapyFin. All rights reserved.

Disclaimer: CapyFin provides financial data and AI analysis for informational purposes only and does not provide investment advice or recommendations. Real-time data and AI outputs may be inaccurate, incomplete, delayed, or contain errors or hallucinations. Investing involves risk, including loss of principal. The service is provided “as is” and we disclaim liability to the fullest extent permitted by law. See our Terms of Service and Privacy Policy.

REGENXBIO (RGNX) Financial Analysis | CapyFin

REGENXBIO

RGNX · NASDAQ🇺🇸

Earnings Dividends Seasonality Metrics

Reported earnings 26 days ago

Previous year: $21.2M

Previous year: -$1.01

Previous year: $50.4M

Previous year: $20.1M

Total Cash and Securities

Previous year: $245M

Cash and Equivalents

Previous year: $245M

Previous year: $466M

Loading...

REGENXBIO

Unlock previous datapoints

REGENXBIO

Unlock previous datapoints

REGENXBIO Revenue by Segment

Revenue by Segment

License and Royalty Revenue

CapyFin.com

Service Revenue

CapyFin.com

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Key Statistics

Market Cap

$401M

P/E Ratio

-2.30

Sector

N/A

Industry

N/A

52-Week High

$15.9

52-Week Low

$5.29

R&D Expenses

$59.6M

G&A Expenses

$22.4M

Total Cash and Securities

$241M